These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29470443)

  • 1. Structure-Antiplatelet Activity Relationships of Novel Ruthenium (II) Complexes: Investigation of Its Molecular Targets.
    Hsia CH; Jayakumar T; Sheu JR; Tsao SY; Velusamy M; Hsia CW; Chou DS; Chang CC; Chung CL; Khamrang T; Lin KC
    Molecules; 2018 Feb; 23(2):. PubMed ID: 29470443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet Activity of a Newly Synthesized Novel Ruthenium (II): A Potential Role for Akt/JNK Signaling.
    Khamrang T; Hung KC; Hsia CH; Hsieh CY; Velusamy M; Jayakumar T; Sheu JR
    Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28448438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel ruthenium (II)-derived organometallic compound, TQ-6, potently inhibits platelet aggregation: Ex vivo and in vivo studies.
    Hsia CH; Velusamy M; Sheu JR; Khamrang T; Jayakumar T; Lu WJ; Lin KH; Chang CC
    Sci Rep; 2017 Aug; 7(1):9556. PubMed ID: 28842683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Benzimidazole Derivatives as Novel Anti-platelet Drugs.
    Yao W-C; Yuan L-T; Yang W-B; Hsia C-H; Huang L-T; Lee T-Y; Sheu J-R; Lu W-J; Jayakumar T; Chen R-J
    Curr Pharm Biotechnol; 2017; 18(7):594-605. PubMed ID: 28828982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible Molecular Targets of Novel Ruthenium Complexes in Antiplatelet Therapy.
    Jayakumar T; Hsu CY; Khamrang T; Hsia CH; Hsia CW; Manubolu M; Sheu JR
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29925802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure⁻Activity Relationship Study of Newly Synthesized Iridium-III Complexes as Potential Series for Treating Thrombotic Diseases.
    Yang CH; Hsia CW; Jayakumar T; Sheu JR; Hsia CH; Khamrang T; Chen YJ; Manubolu M; Chang Y
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ginsenoside-Rp3 inhibits platelet activation and thrombus formation by regulating MAPK and cyclic nucleotide signaling.
    Irfan M; Jeong D; Kwon HW; Shin JH; Park SJ; Kwak D; Kim TH; Lee DH; Park HJ; Rhee MH
    Vascul Pharmacol; 2018 Oct; 109():45-55. PubMed ID: 29890296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationship of three synthesized benzimidazole-based oligosaccharides in human platelet activation.
    Chang Y; Hsu WH; Yang WB; Jayakumar T; Lee TY; Sheu JR; Lu WJ; Li JY
    Int J Mol Med; 2017 Nov; 40(5):1520-1528. PubMed ID: 28949377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet activity of Phellinus baummii methanol extract is mediated by cyclic AMP elevation and inhibition of collagen-activated integrin-α(IIb) β₃ and MAP kinase.
    Kamruzzaman SM; Endale M; Oh WJ; Park SC; Kim TH; Lee IK; Cho JY; Park HJ; Kim SK; Yun BS; Rhee MH
    Phytother Res; 2011 Nov; 25(11):1596-603. PubMed ID: 21394810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro effects of aprosulate sodium, a novel anticoagulant, on platelet activation: possible mechanism for antiplatelet action.
    Sugidachi A; Breiter N; Ogawa T; Asai F; Koike H
    Thromb Haemost; 1996 Nov; 76(5):786-90. PubMed ID: 8950791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of caffeic acid on ADP-induced thrombus formation and platelet activation involves mitogen-activated protein kinases.
    Lu Y; Li Q; Liu YY; Sun K; Fan JY; Wang CS; Han JY
    Sci Rep; 2015 Sep; 5():13824. PubMed ID: 26345207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hinokitiol inhibits platelet activation ex vivo and thrombus formation in vivo.
    Lin KH; Kuo JR; Lu WJ; Chung CL; Chou DS; Huang SY; Lee HC; Sheu JR
    Biochem Pharmacol; 2013 May; 85(10):1478-85. PubMed ID: 23473801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel iridium (III)‑derived organometallic compound for the inhibition of human platelet activation.
    Shyu KG; Velusamy M; Hsia CW; Yang CH; Hsia CH; Chou DS; Jayakumar T; Sheu JR; Li JY
    Int J Mol Med; 2018 May; 41(5):2589-2600. PubMed ID: 29436605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atractylodes lactone compounds inhibit platelet activation.
    Chen Y; Yang W; Guo L; Wu X; Zhang T; Liu J; Zhang J
    Platelets; 2017 Mar; 28(2):194-202. PubMed ID: 27560602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel synthetic benzimidazole-derived oligosaccharide, M3BIM, prevents ex vivo platelet aggregation and in vivo thromboembolism.
    Yen TL; Wu MP; Chung CL; Yang WB; Jayakumar T; Geraldine P; Chou CM; Chang CY; Lu WJ; Sheu JR
    J Biomed Sci; 2016 Feb; 23():26. PubMed ID: 26887315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and pharmacological evaluation of novel beta-nitrostyrene derivatives as tyrosine kinase inhibitors with potent antiplatelet activity.
    Wang WY; Hsieh PW; Wu YC; Wu CC
    Biochem Pharmacol; 2007 Aug; 74(4):601-11. PubMed ID: 17601492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
    Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
    Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-platelet activity of panaxatriol saponins is mediated by suppression of intracellular calcium mobilization and ERK2/p38 activation.
    Qi H; Huang Y; Yang Y; Dou G; Wan F; Zhang W; Yang H; Wang L; Wu C; Li L
    BMC Complement Altern Med; 2016 Jun; 16():174. PubMed ID: 27277000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esculetin, a Coumarin Derivative, Prevents Thrombosis: Inhibitory Signaling on PLCγ2-PKC-AKT Activation in Human Platelets.
    Hsia CW; Lin KC; Lee TY; Hsia CH; Chou DS; Jayakumar T; Velusamy M; Chang CC; Sheu JR
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31163690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological actions of neferine in the modulation of human platelet function.
    Yang RP; Zhou YJ; Song W; Yin Z; He AD; Ming ZY
    Eur J Pharmacol; 2019 Nov; 862():172626. PubMed ID: 31445013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.